Literature DB >> 23192617

IL-1RN +2018T>C polymorphism is correlated with colorectal cancer.

Florin Burada1, Theodor Dumitrescu, Raluca Nicoli, Marius Eugen Ciurea, Cristina Angelescu, Francisc Mixich, Mihai Ioana.   

Abstract

Epidemiological and experimental evidence indicates chronic inflammation as a risk factor for colorectal cancer. We investigated whether IL-1B -511C>T (rs16944), IL-1B +3954C>T (rs1143634) and IL1-RN +2018T>C (rs419598) cytokine polymorphisms are correlated with colorectal cancer. Blood samples were obtained from 377 Romanian subjects: 144 patients with sporadic colorectal cancer and 233 healthy controls. Polymorphisms were analyzed by allelic discrimination TaqMan PCR assays with specific probes. The results of our study showed that IL-1RN +2018T>C polymorphism is associated with colorectal cancer. We found that there was a significant difference in the frequency of CC genotype between patients with colorectal cancer and the control group (OR 2.42, 95 % CI: 1.06-5.53, p = 0,034) when TT genotype was used as reference. Furthermore, in a stratified analysis, a positive association was found only for IL-1RN +2018CC genotype, that was limited to early I and II stages (OR 2.72, 95 % CI: 1.05-7.03, p = 0,033). We did not find any association between any of the IL-1B polymorphisms and colorectal cancer. In conclusion this study found that IL-1RN +2018T>C polymorphism is associated with colorectal cancer, mainly for localized disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192617     DOI: 10.1007/s11033-012-2300-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

Review 1.  Cytokine gene polymorphism in human disease: on-line databases, supplement 2.

Authors:  N Haukim; J L Bidwell; A J P Smith; L J Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  2002-09       Impact factor: 2.676

2.  Inflammation-related gene polymorphisms and colorectal adenoma.

Authors:  Marc J Gunter; Federico Canzian; Stefano Landi; Stephen J Chanock; Rashmi Sinha; Nathaniel Rothman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

Review 3.  The paradox of pro-inflammatory cytokines in cancer.

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

Review 4.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

5.  The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.

Authors:  Mairi Macarthur; Linda Sharp; Georgina L Hold; Julian Little; Emad M El-Omar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

6.  Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.

Authors:  Georg Lurje; Andrew E Hendifar; Anne M Schultheis; Alexandra Pohl; Hatim Husain; Dongyun Yang; Philipp C Manegold; Yan Ning; Wu Zhang; Heinz-Josef Lenz
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

7.  Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies.

Authors:  Alison L Van Dyke; Michele L Cote; Angie S Wenzlaff; Susan Land; Ann G Schwartz
Journal:  Cytokine       Date:  2009-04-07       Impact factor: 3.861

8.  Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST).

Authors:  J B A Crusius; F Canzian; G Capellá; A S Peña; G Pera; N Sala; A Agudo; F Rico; G Del Giudice; D Palli; M Plebani; H Boeing; H B Bueno-de-Mesquita; F Carneiro; V Pala; V E Save; P Vineis; R Tumino; S Panico; G Berglund; J Manjer; R Stenling; G Hallmans; C Martínez; M Dorronsoro; A Barricarte; C Navarro; J R Quirós; N Allen; T J Key; S Binghan; C Caldas; J Linseisen; R Kaaks; K Overvad; A Tjønneland; F C Büchner; P H M Peeters; M E Numans; F Clavel-Chapelon; A Trichopoulou; E Lund; M Jenab; S Rinaldi; P Ferrari; E Riboli; C A González
Journal:  Ann Oncol       Date:  2008-07-14       Impact factor: 32.976

9.  Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany.

Authors:  Natalia Zumkeller; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Alexandra Nieters; Dietrich Rothenbacher
Journal:  Eur J Cancer       Date:  2007-04-18       Impact factor: 9.162

10.  Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1beta.

Authors:  Y Akagi; W Liu; K Xie; B Zebrowski; R M Shaheen; L M Ellis
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more
  6 in total

1.  Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration.

Authors:  Sambhawa Priya; Michael B Burns; Tonya Ward; Ruben A T Mars; Beth Adamowicz; Eric F Lock; Purna C Kashyap; Dan Knights; Ran Blekhman
Journal:  Nat Microbiol       Date:  2022-05-16       Impact factor: 30.964

2.  Inherited variant in NFκB-1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding.

Authors:  Imene Hamadou; Sonia Garritano; Alessandro Romanel; Dalila Naimi; Talel Hammada; Francesca Demichelis
Journal:  Cancer Rep (Hoboken)       Date:  2020-02-20

3.  Association of cytokine gene polymorphisms with osteoarthritis susceptibility.

Authors:  Otilia Constantina Rogoveanu; Daniela Calina; Mihai Gabriel Cucu; Florin Burada; Anca Oana Docea; Simona Sosoi; Emilian Stefan; Mihai Ioana; Emilia Burada
Journal:  Exp Ther Med       Date:  2018-07-18       Impact factor: 2.447

4.  An in silico analytical study of lung cancer and smokers datasets from gene expression omnibus (GEO) for prediction of differentially expressed genes.

Authors:  Atif Noorul Hasan; Mohammad Wakil Ahmad; Inamul Hasan Madar; B Leena Grace; Tarique Noorul Hasan
Journal:  Bioinformation       Date:  2015-05-28

5.  Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study.

Authors:  Haihua Qian; Dan Zhang; Chuanqing Bao
Journal:  Aging (Albany NY)       Date:  2018-12-19       Impact factor: 5.682

6.  Role of IL-1β rs1143634 (+3954C>T) polymorphism in cancer risk: an updated meta-analysis and trial sequential analysis.

Authors:  Sarah Jafrin; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.